PT  - JOURNAL ARTICLE
AU  - Kyagulanyi, Ali
AU  - Muhanguzi, Joel Tibabwetiza
AU  - Oscar, Dembe
TI  - Risk Analysis and Prediction for COVID19 Demographics in Low Resource Settings using a Python Desktop App and Excel Models
AID  - 10.1101/2020.04.13.20063453
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.13.20063453
4099  - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20063453.short
4100  - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20063453.full
AB  - While the novel covid19 disease caused by sar-cov-2 corona virus has proved a serious threat to mankind it being a pandemic, the rate at which technology in low resource income countries like Uganda has been used to predict the spread and impact of the disease in their economies has not been strongly employed. This paper presents a an excel model and desktop application software developed using open source python programming tools for carrying out risk analysis and prediction of demographics for covid19 disease. Prediction results for both models clearly stated using epidemiological curve, these results can vary based on the force of infection which varies based on government measures and actions. With a certain degree of certainty of the potential impact of the disease on low resource countries, it will foster proper planning and strategical methods to properly manage the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe did not receive any fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthere is one link to access of the code